Another study by Pinto et al. validated this method and integrated it with NGS in a Chilean cohort (N = 91) and proposed an improved low-cost stratification system for GC patients that includes assessment of HER2 and PDL1 status [71]. This evidence concerns the gene CD274 and gastric cancer.